سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

N-acetyltransferase 2 (NAT2) genotypes,passive and active smoker and risk of breast cancer

Publish Year: 1397
Type: Conference paper
Language: English
View: 449
این Paper فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن Papers دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

Export:

Link to this Paper:

Document National Code:

WHMED07_299

Index date: 19 June 2019

N-acetyltransferase 2 (NAT2) genotypes,passive and active smoker and risk of breast cancer abstract

Background: Breast cancer is the most common malignancy of women in the world. The disease is caused by infectious and non-infectious, environmental and lifestyle factors.Women who smoke at breast cancer diagnosis have higher risk of breast cancer-specific and all-cause mortality than nonsmokers. N-acetyltransferases (NATs) are important catalytic enzymes that metabolize carcinogenic arylamines. NAT2 genotype might modify the role of cigarette smoking, a source of arylamine exposure, in breast cancer. We conducted a study to investigate the association between NAT2 genotype, smoking and breast cancer risk Methods: : we performed systematic review of literature with related keywords in PubMed,Science direct and Google scholar to gather information in articles published since 2016 and summarized here Results: 347 women diagnosed (2002-2004) with breast cancer and 775 population-based controls. The mailed study package included a questionnaire requesting information aboutestablished breast cancer risk factors, passive and active smoking, and a buccal swab for genetic analyses. Among never-active smokers, a long duration of passive smoking was associated with an increased risk of breast cancer (odds ratio (OR) 1.86 (95% confidence interval (95% CI) 1.01- 3.44) (test for trend (p=0.07)); that risk was more elevated for NAT2 slow acetylators (OR 2.76, 95% CI 1.16-6.59) (and highest in extremely slow acetylators), but not elevated for NAT2 fast acetylators (OR 1.17, 95% CI 0.42-3.23). Among active smokers more than 20 pack-years of smoking was associated with an OR of 1.34 (95% CI 0.92-1.96); more elevated among NAT2 fast acetylators OR 1.93 (95% CI 1.01-3.69) but not elevated among NAT2 slow acetylators. Women who were NAT2 fast acetylators in the highest quartile for duration of active smoking had an OR of 2.74 (95% CI 1.42-5.27), with a significant test of trend (p=0.005) Conclusion: Active smoking was associated with an increase in breast cancer risk among postmenopausal women and the effect may be differentially modified by NAT2 phenotype. was also a suggestion of an association between passive smoking and increased risk of breast cancer

N-acetyltransferase 2 (NAT2) genotypes,passive and active smoker and risk of breast cancer Keywords:

N-acetyltransferase 2 (NAT2) genotypes,passive and active smoker and risk of breast cancer authors

Haniye Khaki

Medical Student,Student Research Committee,Faculty of Medicine,Qom University of Medical Sciences, Qom, Iran

Fatemeh Heidari

Anatomy Department, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran

Mohsen Eslami

Anatomy Department, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran

Kimia Jazi

Medical Student,Student Research Committee,Faculty of Medicine,Qom University of Medical Sciences, Qom, Iran